Clinical trials for Soft Tissue Surgery
IACUC Protocol: # G2017-80
|In both human beings and dogs, local tumor recurrence following surgical removal of solid tumors is a major cause of treatment failure. An important technical limitation is that there is currently no widely available technique for rapid evaluation of the completeness of tumor removal during surgery. To address this need, a handheld imaging device has been developed that can be used in conjunction with injectable fluorescent imaging agents that accumulate in cancerous tissue and are administered to the patient prior to surgery. The imaging device can be used to scan the tumor bed for residual tissue to identify cancer that has not been removed. Removing this tissue has potential to reduce local recurrence rates. The objective of this project is to test the accuracy of the system in distinguishing normal tissue from cancerous tissue in dogs undergoing resection of carcinomas, a common category of cancer in dogs. We hypothesize that the system will have a high level of accuracy in this application.
Any dog with naturally occurring mammary, anal sac, hepatocellular, thyroid or pulmonary carcinomas. Informed client consent will be obtained prior to entering dogs in the study.
Patients with mammary tumors will be considered candidates for the study only if their tumors can be appropriately treated with a standard mass removal as opposed to unilateral or bilateral mastectomy.
You will receive a $500.00 reduction in your total bill as an incentive to participate in this study, and you will not be charged for your initial office visit. Your pet’s participation will allow us to gain information that will help in the treatment of other dogs, cats, and humans undergoing surgical resection of malignant tumors.
For questions regarding the clinical trial please email the clinical trials office: firstname.lastname@example.org